Lecithinized SOD Therapy for ARDS Edema and Lung Injury
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for acute respiratory distress syndrome (ARDS) and ventilator-induced lung injury (VILI) are inadequate, with high mortality rates and limited effectiveness from existing therapies such as steroids and sivelestat, and there is a need for a more effective therapeutic agent that can address edema, tissue injury, and inflammation in the lungs and other organs.
Innovation Solution
A lecithinized superoxide dismutase (PC-SOD) is used as an active ingredient in an agent for treating ARDS, formulated with a chemical crosslinking agent and a stabilizing agent like sucrose to enhance its effectiveness and stability, administered via injection or inhalation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (steroids, sivelestat) are used for ARDS, then treatment is provided, but mortality rate remains high (40-50%) and effectiveness is limited
Solution Approach 1:
The patent modifies the chemical structure of superoxide dismutase by conjugating it with lecithin (phosphatidylcholine) to create PC-SOD. This parameter change in molecular structure improves tissue affinity and stability in blood plasma, transforming it from a conventional enzyme to an enhanced therapeutic agent that effectively reduces edema, tissue injury, and inflammation in ARDS patients
Solution Approach 2:
The patent creates a composite enzyme-lectithin conjugate (PC-SOD) by chemically binding lecithin molecules to superoxide dismutase. This composite structure combines the catalytic activity of SOD with the membrane-affinity and stability properties of lecithin, resulting in a therapeutic agent that penetrates lung tissue more effectively and persists longer in the bloodstream
2Ease of operation
If mechanical ventilation is used for ARDS patients, then respiratory support is provided, but ventilator-induced lung injury (VILI) occurs increasing mortality
Solution Approach 1:
The patent converts the harmful effect of mechanical ventilation (VILI) into a treatable condition by using PC-SOD to neutralize the reactive oxygen species and inflammatory cytokines that cause lung injury during ventilation. The therapeutic agent transforms the harmful physiological stress of mechanical ventilation into a manageable condition that can be actively treated
3Stability of the object's composition
If high pressure mechanical ventilation is used, then lung compliance is improved, but tissue injury and edema worsen
Solution Approach 1:
The patent introduces PC-SOD as an intermediary substance that mediates between the mechanical ventilation process and the lung tissue. The conjugated enzyme neutralizes harmful reactive oxygen species and inflammatory mediators generated during high-pressure ventilation, protecting tissue while allowing ventilation to maintain lung compliance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
PC-SOD effectively reduces edema, tissue injury, and inflammation in the lungs and other organs, offering a new hope for treating ARDS and VILI by improving survival rates and lung function.
Implementation Method 1
lecithinized superoxide dismutase (PC-SOD) as an active ingredient... PC-SOD effectively reduces edema, tissue injury, and inflammation
Data Source
AI summary
An agent for treating acute respiratory distress syndrome includes, as an active ingredient, a lecithinized superoxide dismutase represented by the general formula (I):SOD′(Q-B)m (I)(wherein, SOD′ represents a residue of a superoxide dismutase; Q represents a chemical crosslinking; B represents a residue of lysolecithin, in which a hydrogen atom of a hydroxyl group is removed from the lysolecithin having the hydroxyl group at the 2-position of glycerol; and m is the average number of bonds of the lysolecithin relative to one molecule of the superoxide dismutase and represents an integer of 1 or more).